Related Experiment Video
Updated: Feb 8, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
In Vitro and In Vivo IgE-/Antigen-Mediated Mast Cell Activation
Hae Woong Choi1, Soman N Abraham2,3,4,5
1Department of Pathology, Duke University Medical Center, Durham, NC, USA. haewoong.choi@duke.edu.
Abstract:
Mast cells (MCs) are major effectors of IgE-mediated allergic reactions because of their unique peripheral location and their powerful capacity to release prestored and de novo-synthesized inflammatory mediators into the circulation upon activation. In view of the growing incidence of allergy worldwide, there is much interest in developing novel strategies to block or temper IgE-mediated MC activation and its pathological consequences. For these studies, standard assays to measure IgE-mediated MC degranulation and mediator release are required. Here, we present detailed procedures to assess in vitro and in vivo MC release of prestored as well as recently synthesized mediators following IgE-/antigen-mediated activation.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Equivalence: In Vitro and In Vivo Bioequivalence
Receptor-mediated Endocytosis
Cell-mediated Immune Responses

